Sort
23,748 grants matching “melanoma”
USE OF NMR TO MEASURE TUMOR AND NORMAL TISSUE METAB DURING TUMOR ACIDIFICATION
$228,401Thomas Jefferson University · P01 · FY2002 · CA
PH REGULATION IN MELANOMA CELLS ADAPTED TO GROWTH AT LOW PH
$228,401Thomas Jefferson University · P01 · FY2002 · CA
PH REGULATION IN MELANOMA CELLS ADAPTED TO GROWTH AT LOW PH
$228,401Thomas Jefferson University · P01 · FY2002 · CA
ACIDIFICATION OF HUMAN MELANOMA XENOGRAFTS
$228,401Thomas Jefferson University · P01 · FY2002 · CA
CORE--ANIMAL
$228,401Thomas Jefferson University · P01 · FY2002 · CA
USE OF NMR TO MEASURE TUMOR AND NORMAL TISSUE METAB DURING TUMOR ACIDIFICATION
$228,401Thomas Jefferson University · P01 · FY2002 · CA
HSPS, CYTOSKELETAL AND SURVIVAL RESISTANCE TO HEAT TO LOW PH ADAPTED CELLS
$228,401Thomas Jefferson University · P01 · FY2002 · CA
ACIDIFICATION OF HUMAN MELANOMA XENOGRAFTS
$228,401Thomas Jefferson University · P01 · FY2002 · CA
CORE--ANIMAL
$228,401Thomas Jefferson University · P01 · FY2002 · CA
HSPS, CYTOSKELETAL AND SURVIVAL RESISTANCE TO HEAT TO LOW PH ADAPTED CELLS
$228,401Thomas Jefferson University · P01 · FY2002 · CA
(PQA1) Molecular Mechanism of Metformin in Cancer
$228,375Chengkai Dai · Jackson Laboratory · R21 · FY2015 · CA
SIGNALING MECHANISMS FOR WNT PROTEINS
$228,375University Of Connecticut Sch Of Med/Dnt · R01 · FY2004 · CA
SIGNALING MECHANISMS FOR WNT PROTEINS
$228,375University Of Connecticut Sch Of Med/Dnt · R01 · FY2005 · CA
Natural Product Antitumor Inducers of Apoptosis
$228,321University Of California Davis · R01 · FY2002 · CA
T CELL COSTIMULATION IN ANTITUMOR RESPONSES
$228,262University Of California Berkeley · R01 · FY2000 · CA
Carbohydrate- Dependent Epithelial Cancer Metastasis
$228,257Michiko N Fukuda · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2009 · CA
Developmental and Homeostatic origins of cancer
$228,237Sridhar Hannenhalli · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Evaluate the antiangiogenic properties of mda-7/IL-24
$228,190University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA
Phase II Study of Imatinib Mesylate in Patients with Inoperable Melanoma
$228,114Gary K Schwartz · Sloan-Kettering Inst Can Research · R01 · FY2010 · FD
Regulation of the innate immune response in the tumor microenvironment of lung adenocarcinoma
$228,099Glenn Edward Simmons · Cornell University · K01 · FY2024 · CA
Human Immunology Core
$228,089Caryn Lerman · University Of Pennsylvania · P30 · FY2014 · CA
Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology
$228,089David Liu · Dana-Farber Cancer Inst · K08 · FY2019 · CA
Potentiating the Effects of Targeted and Cytotoxic Agents on Cell-Based Immunoth
$228,065Dmitry Isaac Gabrilovich · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2013 · CA
Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy
$228,008Martin McMahon · University Of California, San Francisco · R01 · FY2015 · CA
THE ROLE OF IL-34 IN THE BIOLOGY OF LANGERHANS CELLS
$228,000Marco Colonna · Washington University · R21 · FY2014 · AI